


Contact Us | News | Site Map
Aridis Pharmaceuticals © 2010 Le3 Web Designs
Convenient, Effective Therapies
for Infectious Diseases
June 29th, 2010. Aridis receives notice of award from the US Department of Defense totaling $2.4m to develop gallium based antimicrobial for topical treatment of wound infection pathogens.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
July 23rd,
2010. Aridis receives notice of award from the US Dept. of Health & Human Services
totaling $3m to develop stable formulation for influenza vaccines.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
January 8th, 2010 Aridis out-
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
September 30th, 2009 Aridis awarded a National Institute of Health grant award to develop advanced formulation for third generation anthrax vaccines.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
June 17th, 2009 Aridis awarded SBIR Award from the National Institute of Allergy and Infectious Diseases, NIH to develop inhalable gallium based therapeutics.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
January 29th, 2009Aridis awarded U.S. Agency for International Development (USAID) award in collaboration with Mapp BioPharmaceutical to develop microbicides monoclonal antibodies.
>> More news


